InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,465.39
(
0.01%
)
US TECH 100
18,996.40
(
-1.10%
)
Dow Jones
39,432.22
(
0.72%
)
Brent Oil
85.21
(
1.41%
)
Bitcoin
60,307.51
(
-4.51%
)
Post# of 252328
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119906
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: pcrutch post# 113863

Thursday, 02/03/2011 6:43:35 PM

Thursday, February 03, 2011 6:43:35 PM

Post# of 252328
PDSV/ALIM—36-month Iluvien results were not statsig:

http://finance.yahoo.com/news/pSivida-Announces-Positive-bw-53373774.html?x=0&.v=1

Trial A:

The therapeutic effect was maintained at month 36 (with 28.4% of patients gaining 15 or more letters); however, as 18.9% of the control group gained 15 or more letters, the p value increased to p=0.106.

Trial B:

At month 36, 29.0% of ILUVIEN patients gained 15 or more letters compared with 18.9% of control patients (p=0.086).

It looks like I can keep posting after all (#msg-44824336) :- )

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up